Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0845da5b20c0d87091a601362e76136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17 |
filingDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e59246525bb5843439dd7d75ebee48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a43c117abebfe4ce26edc3cf67ca66 |
publicationDate |
2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020196953-A1 |
titleOfInvention |
Pharmaceutical composition, for preventing or treating inflammatory diseases, comprising osteocalcin |
abstract |
The present invention relates to a pharmaceutical composition for effectively preventing or treating inflammatory diseases. A pharmaceutical composition comprising undercarboxylated osteocalcin according to the present invention can effectively inhibit the production of TNF-α, IL-1β or IL-6 which are inflammatory cytokine, and thus can be utilized in various industry fields such as drugs and foods as a substance for preventing, treating or alleviating various inflammatory diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114432429-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114748610-A |
priorityDate |
2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |